Department of Pediatric Oncology and Hematology CVK

Projects

• ALL-REZ BFM 2002
• Emotionale Regulation und Verarbeitung bei Geschwistern von an Leukämie erkrankten Kindern
• ETV6/RUNX1-Inhibition
• FeCt-Offspring study nationwide
• Improved risk assignment of children relapsed acute lymphoblastic leukemia using molecular genetic markers
• Isolated extramedullary relapses and submicroscopic bone marrow involvement
• Isolated extramedullary relapses and submicroscopic bone marrow involvement - new definition of site of relapse
• Klonale Marker und Kinetiken von Haupt- und Subklonen bei ALL im Kindesalter
• Labormethodenseminar MAXIMAL METHODISCH
• Molecular Mechanisms of Mistletoe Plant Extract-Induced Apoptosis in Acute Lymphoblastic Leukemia in vitro/in vivo
• Molekulare Mechanismen von Viscum album L. Extrakten und isolierten Wirkstoffen in einem ALL-Modell
• MRD bei ALL-Rezidiv
• MRD-Nachweis zu definierten Zeitpunkten während der Therapie in der Behandlung von Kindern mit ALL-Rezidiv
• New drug combinations with HDACi for treatment of children with ALL
• Palliative Versorg. v. Kindern
• Preclinical evaluation of new treatment combinations with HDACis for the therapy of chilhood ALL
• Prognostic importance and clonal origin of chromosome 21 amplifications in relapsed childhood ALL
• Promotionsstipendium Vagkopoulou
• Prospektiver systematischer Vergleich von klonalen Markern und Kinetiken von Haupt- und Subklonen
• StepOnePlus
• Targeted therapy of refractory childhood ALL
• The role of cIAP1/2 in lymphopoiesis, leukemogenesis and resistance against chemotherapy in childhhod ALL
• The role of the X-linked inhibitor of apoptosis protein (XIAP) in childhood acute lymphoblastic leukemia
• Therapeutic efficiency of VAE
• XIAP inhibition as novel treatment strategy in childhood ALL relapse

If the list does not contain any entry, the request was executed without results.